Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP400712.RA3tMkn2QELfa6B8uooJygP7lWJOKI-NiFJcdO2bil2hA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP400712.RA3tMkn2QELfa6B8uooJygP7lWJOKI-NiFJcdO2bil2hA130_assertion type Assertion NP400712.RA3tMkn2QELfa6B8uooJygP7lWJOKI-NiFJcdO2bil2hA130_head.
- NP400712.RA3tMkn2QELfa6B8uooJygP7lWJOKI-NiFJcdO2bil2hA130_assertion description "[We subjected 13 cases of CLC to a comprehensive molecular analysis including immunohistochemistry for E-cadherin, estrogen and progesterone receptors, HER2/neu and p53; high-resolution comparative genomic hybridization (HR-CGH); microarray-based CGH (aCGH); and fluorescent and chromogenic in situ hybridization for CCND1 and FGFR1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400712.RA3tMkn2QELfa6B8uooJygP7lWJOKI-NiFJcdO2bil2hA130_provenance.
- NP400712.RA3tMkn2QELfa6B8uooJygP7lWJOKI-NiFJcdO2bil2hA130_assertion evidence source_evidence_literature NP400712.RA3tMkn2QELfa6B8uooJygP7lWJOKI-NiFJcdO2bil2hA130_provenance.
- NP400712.RA3tMkn2QELfa6B8uooJygP7lWJOKI-NiFJcdO2bil2hA130_assertion SIO_000772 17121884 NP400712.RA3tMkn2QELfa6B8uooJygP7lWJOKI-NiFJcdO2bil2hA130_provenance.
- NP400712.RA3tMkn2QELfa6B8uooJygP7lWJOKI-NiFJcdO2bil2hA130_assertion wasDerivedFrom befree-20150227 NP400712.RA3tMkn2QELfa6B8uooJygP7lWJOKI-NiFJcdO2bil2hA130_provenance.
- NP400712.RA3tMkn2QELfa6B8uooJygP7lWJOKI-NiFJcdO2bil2hA130_assertion wasGeneratedBy ECO_0000203 NP400712.RA3tMkn2QELfa6B8uooJygP7lWJOKI-NiFJcdO2bil2hA130_provenance.